News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma
Photo of Christine Ryland taken from Christine Ryland/LinkedIn
Aug 14, 2024, 07:24

Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma

Christine Ryland shared on LinkedIn:

“I’m happy to share that I have started a new position as Director, Thought Leader Liaison for the multiple myeloma team at Kite Pharma!”

Christine Ryland as Director of Thought Leader Liaison for the multiple myeloma team at Kite Pharma

Source: Christine Ryland/LinkedIn

Christine Ryland is a seasoned pharmaceutical professional with expertise in sales, marketing, and KOL (Key Opinion Leader) strategic engagement. Currently serving as Director of Thought Leader Liaison at Kite Pharma, she previously held the role of KOL Strategic Engagement/Field Marketing Lead for Multiple Myeloma and Leukemia at Takeda Oncology.

Christine has a proven track record of leading cross-functional teams and effectively bridging commercial and medical objectives to drive success in the oncology field.

cancer career achievement Christine Ryland Kite Pharma multiple myeloma OncoDaily Oncology Thought Leader Liaison
Special Coverage
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus